These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25735358)

  • 41. Significance of lymphadenectomy with splenectomy in radical surgery for advanced (pT3/pT4) remnant gastric cancer.
    Sugita H; Oda E; Hirota M; Ishikawa S; Tomiyasu S; Tanaka H; Arita T; Yagi Y; Baba H
    Surgery; 2016 Apr; 159(4):1082-9. PubMed ID: 26497772
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Surgical treatment and prognosis of gastric stump cancer].
    Zhou LX; Zhang ZW; Xu ZY
    Ai Zheng; 2009 May; 28(5):511-4. PubMed ID: 19624880
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Integration of radiotherapy and chemotherapy for abdominal lymph node recurrence in gastric cancer.
    Lee J; Yoon HI; Rha SY; Hyung WJ; Lee YC; Lim JS; Kim HS; Koom WS
    Clin Transl Oncol; 2017 Oct; 19(10):1268-1275. PubMed ID: 28477237
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer.
    Hanazaki K; Mochizuki Y; Machida T; Yokoyama S; Sodeyama H; Sode Y; Wakabayashi M; Kawamura N; Miyazaki T
    Hepatogastroenterology; 1999; 46(26):1238-43. PubMed ID: 10370699
    [TBL] [Abstract][Full Text] [Related]  

  • 45. mRNA expression of BRCA1, PIAS1, and PIAS4 and survival after second-line docetaxel in advanced gastric cancer.
    Wei J; Costa C; Ding Y; Zou Z; Yu L; Sanchez JJ; Qian X; Chen H; Gimenez-Capitan A; Meng F; Moran T; Benlloch S; Taron M; Rosell R; Liu B
    J Natl Cancer Inst; 2011 Oct; 103(20):1552-6. PubMed ID: 21862729
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia.
    Chon HJ; Hyung WJ; Kim C; Park S; Kim JH; Park CH; Ahn JB; Kim H; Chung HC; Rha SY; Noh SH; Jeung HC
    Ann Surg; 2017 May; 265(5):946-953. PubMed ID: 27232252
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Loss of ACSS2 expression predicts poor prognosis in patients with gastric cancer.
    Hur H; Kim YB; Ham IH; Lee D
    J Surg Oncol; 2015 Nov; 112(6):585-91. PubMed ID: 26381042
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinoma.
    Chirieac LR; Swisher SG; Correa AM; Ajani JA; Komaki RR; Rashid A; Hamilton SR; Wu TT
    Clin Cancer Res; 2005 Mar; 11(6):2229-36. PubMed ID: 15788671
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
    Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
    Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study.
    Iveson T; Donehower RC; Davidenko I; Tjulandin S; Deptala A; Harrison M; Nirni S; Lakshmaiah K; Thomas A; Jiang Y; Zhu M; Tang R; Anderson A; Dubey S; Oliner KS; Loh E
    Lancet Oncol; 2014 Aug; 15(9):1007-18. PubMed ID: 24965569
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Disparities in gastric cancer outcomes among Asian ethnicities in the USA.
    Kim J; Mailey B; Senthil M; Artinyan A; Sun CL; Bhatia S
    Ann Surg Oncol; 2009 Sep; 16(9):2433-41. PubMed ID: 19582508
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Analysis of clinicopathological characteristics and prognosis on 42 patients with primary gastric adenosquamous cell carcinoma].
    Li B; Sun L; Wang X; Deng J; Ding X; Wang X; Ke B; Zhang L; Zhang R; Liang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):207-212. PubMed ID: 28226357
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinicopathologic features of gastric cancer with synchronous and metachronous colorectal cancer in Korea: are microsatellite instability and p53 overexpression useful markers for predicting colorectal cancer in gastric cancer patients?
    Kim HJ; Kim N; Choi YJ; Yoon H; Shin CM; Park YS; Lee HS; Ahn SH; Park do J; Kim HH; Son IT; Kang SB; Lee DH
    Gastric Cancer; 2016 Jul; 19(3):798-807. PubMed ID: 26445944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery.
    Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Mohri Y; Kusunoki M
    Anticancer Res; 2013 Nov; 33(11):5065-74. PubMed ID: 24222151
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinicopathological Characteristics and Survival Outcomes of Primary Signet Ring Cell Carcinoma in the Stomach: Retrospective Analysis of Single Center Database.
    Liu X; Cai H; Sheng W; Yu L; Long Z; Shi Y; Wang Y
    PLoS One; 2015; 10(12):e0144420. PubMed ID: 26642199
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Young-onset rectal cancer: presentation, pattern of care and long-term oncologic outcomes compared to a matched older-onset cohort.
    You YN; Dozois EJ; Boardman LA; Aakre J; Huebner M; Larson DW
    Ann Surg Oncol; 2011 Sep; 18(9):2469-76. PubMed ID: 21448750
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Role of Surgical Resection for Stage IV Gastric Cancer With Synchronous Hepatic Metastasis.
    Picado O; Dygert L; Macedo FI; Franceschi D; Sleeman D; Livingstone AS; Merchant N; Yakoub D
    J Surg Res; 2018 Dec; 232():422-429. PubMed ID: 30463751
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modest overall survival improvements from 1998 to 2009 in metastatic gastric cancer patients: a population-based SEER analysis.
    Ebinger SM; Warschkow R; Tarantino I; Schmied BM; Güller U; Schiesser M
    Gastric Cancer; 2016 Jul; 19(3):723-34. PubMed ID: 26391158
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognosis of Ulcerative Colitis-Associated Colorectal Carcinoma Compared to Sporadic Colorectal Carcinoma: A Matched Pair Analysis.
    Leowardi C; Schneider ML; Hinz U; Harnoss JM; Tarantino I; Lasitschka F; Ulrich A; Büchler MW; Kadmon M
    Ann Surg Oncol; 2016 Mar; 23(3):870-6. PubMed ID: 26467453
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A review of carcinoma of the stomach at a tertiary care referral hospital.
    Walker MJ
    Am J Surg; 1996 Jul; 172(1):75-8. PubMed ID: 8686807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.